Agoracom: Small Cap Investment - Zenith Epigenetics - Make your best BET: The emerging role of BET inhibitor treatment in malignant tumors

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Make your best BET: The emerging role of BET inhibitor treatment in malignant tumors

posted on Feb 19, 2020 02:59PM

Great BET inhibitor review for oncology indications.

Make your best BET: The emerging role of BET inhibitor treatment in malignant tumors

https://www.ncbi.nlm.nih.gov/pubmed/31931101

https://www.sciencedirect.com/science/article/pii/S0163725820300073

5 Recommendations

Re: Make your best BET: The emerging role of BET inhibitor treatment in malignant tumors